ArticlePloS one2019

Mutant prevention concentration of ozenoxacin for quinolone-susceptible or -resistant Staphylococcus aureus and Staphylococcus epidermidis.

Y López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.